Literature DB >> 21984974

Temporal dissection of tumorigenesis in primary cancers.

Steffen Durinck1, Christine Ho, Nicholas J Wang, Wilson Liao, Lakshmi R Jakkula, Eric A Collisson, Jennifer Pons, Sai-Wing Chan, Ernest T Lam, Catherine Chu, Kyunghee Park, Sung-woo Hong, Joe S Hur, Nam Huh, Isaac M Neuhaus, Siegrid S Yu, Roy C Grekin, Theodora M Mauro, James E Cleaver, Pui-Yan Kwok, Philip E LeBoit, Gad Getz, Kristian Cibulskis, Jon C Aster, Haiyan Huang, Elizabeth Purdom, Jian Li, Lars Bolund, Sarah T Arron, Joe W Gray, Paul T Spellman, Raymond J Cho.   

Abstract

Timely intervention for cancer requires knowledge of its earliest genetic aberrations. Sequencing of tumors and their metastases reveals numerous abnormalities occurring late in progression. A means to temporally order aberrations in a single cancer, rather than inferring them from serially acquired samples, would define changes preceding even clinically evident disease. We integrate DNA sequence and copy number information to reconstruct the order of abnormalities as individual tumors evolve for 2 separate cancer types. We detect vast, unreported expansion of simple mutations sharply demarcated by recombinative loss of the second copy of TP53 in cutaneous squamous cell carcinomas (cSCC) and serous ovarian adenocarcinomas, in the former surpassing 50 mutations per megabase. In cSCCs, we also report diverse secondary mutations in known and novel oncogenic pathways, illustrating how such expanded mutagenesis directly promotes malignant progression. These results reframe paradigms in which TP53 mutation is required later, to bypass senescence induced by driver oncogenes.

Entities:  

Keywords:  Notch; cancer genetics; genomic; mutation; p53

Mesh:

Substances:

Year:  2011        PMID: 21984974      PMCID: PMC3187561          DOI: 10.1158/2159-8290.CD-11-0028

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  24 in total

Review 1.  Progression model for pancreatic cancer.

Authors:  R H Hruban; M Goggins; J Parsons; S E Kern
Journal:  Clin Cancer Res       Date:  2000-08       Impact factor: 12.531

2.  Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.

Authors:  Andrew P Weng; Adolfo A Ferrando; Woojoong Lee; John P Morris; Lewis B Silverman; Cheryll Sanchez-Irizarry; Stephen C Blacklow; A Thomas Look; Jon C Aster
Journal:  Science       Date:  2004-10-08       Impact factor: 47.728

3.  Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation.

Authors:  J Milner; E A Medcalf
Journal:  Cell       Date:  1991-05-31       Impact factor: 41.582

Review 4.  A genetic model for colorectal tumorigenesis.

Authors:  E R Fearon; B Vogelstein
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

5.  p53 and E2F-1 cooperate to mediate apoptosis.

Authors:  X Wu; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

6.  The patterns and dynamics of genomic instability in metastatic pancreatic cancer.

Authors:  Peter J Campbell; Shinichi Yachida; Laura J Mudie; Philip J Stephens; Erin D Pleasance; Lucy A Stebbings; Laura A Morsberger; Calli Latimer; Stuart McLaren; Meng-Lay Lin; David J McBride; Ignacio Varela; Serena A Nik-Zainal; Catherine Leroy; Mingming Jia; Andrew Menzies; Adam P Butler; Jon W Teague; Constance A Griffin; John Burton; Harold Swerdlow; Michael A Quail; Michael R Stratton; Christine Iacobuzio-Donahue; P Andrew Futreal
Journal:  Nature       Date:  2010-10-28       Impact factor: 49.962

7.  p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.

Authors:  S J Baker; A C Preisinger; J M Jessup; C Paraskeva; S Markowitz; J K Willson; S Hamilton; B Vogelstein
Journal:  Cancer Res       Date:  1990-12-01       Impact factor: 12.701

Review 8.  The scientific basis of skin cancer.

Authors:  D J Leffell
Journal:  J Am Acad Dermatol       Date:  2000-01       Impact factor: 11.527

9.  Genome remodelling in a basal-like breast cancer metastasis and xenograft.

Authors:  Li Ding; Matthew J Ellis; Shunqiang Li; David E Larson; Ken Chen; John W Wallis; Christopher C Harris; Michael D McLellan; Robert S Fulton; Lucinda L Fulton; Rachel M Abbott; Jeremy Hoog; David J Dooling; Daniel C Koboldt; Heather Schmidt; Joelle Kalicki; Qunyuan Zhang; Lei Chen; Ling Lin; Michael C Wendl; Joshua F McMichael; Vincent J Magrini; Lisa Cook; Sean D McGrath; Tammi L Vickery; Elizabeth Appelbaum; Katherine Deschryver; Sherri Davies; Therese Guintoli; Li Lin; Robert Crowder; Yu Tao; Jacqueline E Snider; Scott M Smith; Adam F Dukes; Gabriel E Sanderson; Craig S Pohl; Kim D Delehaunty; Catrina C Fronick; Kimberley A Pape; Jerry S Reed; Jody S Robinson; Jennifer S Hodges; William Schierding; Nathan D Dees; Dong Shen; Devin P Locke; Madeline E Wiechert; James M Eldred; Josh B Peck; Benjamin J Oberkfell; Justin T Lolofie; Feiyu Du; Amy E Hawkins; Michelle D O'Laughlin; Kelly E Bernard; Mark Cunningham; Glendoria Elliott; Mark D Mason; Dominic M Thompson; Jennifer L Ivanovich; Paul J Goodfellow; Charles M Perou; George M Weinstock; Rebecca Aft; Mark Watson; Timothy J Ley; Richard K Wilson; Elaine R Mardis
Journal:  Nature       Date:  2010-04-15       Impact factor: 49.962

10.  Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma.

Authors:  S L Cooke; C K Y Ng; N Melnyk; M J Garcia; T Hardcastle; J Temple; S Langdon; D Huntsman; J D Brenton
Journal:  Oncogene       Date:  2010-06-28       Impact factor: 9.867

View more
  116 in total

Review 1.  Genetic and non-genetic clonal diversity in cancer evolution.

Authors:  James R M Black; Nicholas McGranahan
Journal:  Nat Rev Cancer       Date:  2021-03-16       Impact factor: 60.716

2.  Reconstructing cancer genomes from paired-end sequencing data.

Authors:  Layla Oesper; Anna Ritz; Sarah J Aerni; Ryan Drebin; Benjamin J Raphael
Journal:  BMC Bioinformatics       Date:  2012-04-19       Impact factor: 3.169

3.  Targeting Notch1 and IKKα Enhanced NF-κB Activation in CD133+ Skin Cancer Stem Cells.

Authors:  Zhong Chen; Carter Van Waes; Xin Xin Quan; Nga Voong Hawk; Weiping Chen; Jamie Coupar; Steven K Lee; David W Petersen; Paul S Meltzer; Andrew Montemarano; Martin Braun
Journal:  Mol Cancer Ther       Date:  2018-06-29       Impact factor: 6.261

4.  Cancer-Associated Mutations in Breast Tumor Kinase/PTK6 Differentially Affect Enzyme Activity and Substrate Recognition.

Authors:  Tiffany Tsui; W Todd Miller
Journal:  Biochemistry       Date:  2015-05-13       Impact factor: 3.162

5.  Error-Prone Replication through UV Lesions by DNA Polymerase θ Protects against Skin Cancers.

Authors:  Jung-Hoon Yoon; Mark J McArthur; Jeseong Park; Debashree Basu; Maki Wakamiya; Louise Prakash; Satya Prakash
Journal:  Cell       Date:  2019-02-14       Impact factor: 41.582

6.  Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors.

Authors:  Ayse Selen Yilmaz; Hatice Gulcin Ozer; Jessica L Gillespie; Dawn C Allain; Madison N Bernhardt; Karina Colossi Furlan; Leticia T F Castro; Sara B Peters; Priyadharsini Nagarajan; Stephen Y Kang; O Hans Iwenofu; Thomas Olencki; Theodoros N Teknos; Amanda Ewart Toland
Journal:  Cancer       Date:  2016-12-01       Impact factor: 6.860

7.  A general framework for analyzing tumor subclonality using SNP array and DNA sequencing data.

Authors:  Bo Li; Jun Z Li
Journal:  Genome Biol       Date:  2014-09-25       Impact factor: 13.583

Review 8.  Tumour heterogeneity and the evolutionary trade-offs of cancer.

Authors:  Jean Hausser; Uri Alon
Journal:  Nat Rev Cancer       Date:  2020-02-24       Impact factor: 60.716

Review 9.  Lessons learned from next-generation sequencing in head and neck cancer.

Authors:  Myriam Loyo; Ryan J Li; Chetan Bettegowda; Curtis R Pickering; Mitchell J Frederick; Jeffrey N Myers; Nishant Agrawal
Journal:  Head Neck       Date:  2012-08-21       Impact factor: 3.147

Review 10.  Molecular cancer prevention: Current status and future directions.

Authors:  Karen Colbert Maresso; Kenneth Y Tsai; Powel H Brown; Eva Szabo; Scott Lippman; Ernest T Hawk
Journal:  CA Cancer J Clin       Date:  2015-08-18       Impact factor: 508.702

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.